2015
DOI: 10.1016/j.talanta.2015.02.041
|View full text |Cite
|
Sign up to set email alerts
|

Oxidized phosphatidylcholines suggest oxidative stress in patients with medium-chain acyl-CoA dehydrogenase deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
33
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(38 citation statements)
references
References 37 publications
3
33
1
1
Order By: Relevance
“…A recent manuscript by Najdekr et al showed elevated oxidized phosphatidylcholines in patients with medium-chain acyl-CoA dehydrogenase deficiency [11], a result not seen in this study. Nevertheless, our findings and those of Najdekr et al indicate that compromised mitochondrial fatty acid oxidation clearly impacts complex lipid homeostasis.…”
Section: Discussioncontrasting
confidence: 76%
“…A recent manuscript by Najdekr et al showed elevated oxidized phosphatidylcholines in patients with medium-chain acyl-CoA dehydrogenase deficiency [11], a result not seen in this study. Nevertheless, our findings and those of Najdekr et al indicate that compromised mitochondrial fatty acid oxidation clearly impacts complex lipid homeostasis.…”
Section: Discussioncontrasting
confidence: 76%
“…Besides energy production defects, other pathogenic mechanisms have also been reported. The increased oxidative stress in MCADD patients contributes to the phenotypes, which suggests that antioxidative treatment could be useful in MCADD individuals. Also, accumulation of decanoic and cis‐4‐decanoic acids in MCADD patient tissues disturbs mitochondrial function in the brain and liver, and is possibly involved in the neuropathology and liver dysfunction …”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, increased oxidative stress, due to the disruption of OXPHOS, may also be contributing to MCAD deficiency disease pathogenesis. Increased ROS production has been reported in patients with MCAD deficiency [86,87], while cells lacking MCAD expression exhibit elevated ROS generation associated with increased sensitivity to OXPHOS complex III inhibition [24].…”
Section: Emerging Links Between B-fao and Oxphos In Pathophysiologymentioning
confidence: 99%